Trial · NCT02431702
Results by group157
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 157
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Part-2 (Disease Progression): Time to First Treatment Failure | Part-2: Paliperidone Palmitate (PP) | NA | 95% Confidence Interval 263.0 to NA | days | |
| Part-2 (Disease Progression): Time to First Treatment Failure | Part-2: OAP | NA | 95% Confidence Interval NA to NA | days | |
| Part 3 (Extended Disease Progression [EDP]): Change From Baseline in Cognition as Measured by the MATRICS Consensus Cognitive Battery (MCCB) Composite Score | Part 3-PP to PP | 1.6 | Standard Error 1.19 | T-score | |
| Part 3 (Extended Disease Progression [EDP]): Change From Baseline in Cognition as Measured by the MATRICS Consensus Cognitive Battery (MCCB) Composite Score | Part 3-OAP to OAP | 3.2 | Standard Error 1.11 | T-score | |
| Part 3 (Disease Modification): Change From Baseline in Cognition as Measured by the MATRICS Consensus Cognitive Battery (MCCB) Composite Score | Part 3- PP to PP | -0.7 | Standard Error 1.02 | T-score | |
| Part 3 (Disease Modification): Change From Baseline in Cognition as Measured by the MATRICS Consensus Cognitive Battery (MCCB) Composite Score | Part 3- OAP to PP (or Delayed-Start PP) | -0.2 | Standard Error 0.95 | T-score | |
| Part 3 (Disease Modification): Change From Baseline in Cognition as Measured by the MATRICS Consensus Cognitive Battery (MCCB) Composite Score | Part 3-OAP to OAP | 0.5 | Standard Error 0.96 | T-score | |
| Part 2 (Disease Progression): Change From Baseline in Cognition as Measured by the MATRICS Consensus Cognitive Battery (MCCB) Composite Score | Part-2: Paliperidone Palmitate (PP) | 2.0 | Standard Error 1.01 | T-score | |
| Part 2 (Disease Progression): Change From Baseline in Cognition as Measured by the MATRICS Consensus Cognitive Battery (MCCB) Composite Score | Part-2: OAP | 2.8 | Standard Error 0.73 | T-score | |
| Part 2 (Disease Progression): Change From Baseline in Functioning as Measured by the Personal and Social Performance (PSP) Total Score | Part-2: Paliperidone Palmitate (PP) | 2.5 | Standard Error 1.60 | units on a scale | |
| Part 2 (Disease Progression): Change From Baseline in Functioning as Measured by the Personal and Social Performance (PSP) Total Score | Part-2: OAP | 2.9 | Standard Error 1.13 | units on a scale | |
| Part 2 (Disease Progression): Change From Baseline in Adjusted Intracortical Myelin (ICM) Fraction Score as Measured by Inversion Recovery (IR) and Spin Echo Magnetic Resonance Imaging (MRI) | Part-2: Paliperidone Palmitate (PP) | -0.001 | Standard Error 0.002 | ratio | |
| Part 2 (Disease Progression): Change From Baseline in Adjusted Intracortical Myelin (ICM) Fraction Score as Measured by Inversion Recovery (IR) and Spin Echo Magnetic Resonance Imaging (MRI) | Part-2: OAP | -0.004 | Standard Error 0.001 | ratio | |
| Part 2 (Disease Progression): Change From Baseline in Working Memory Score: MCCB Domain | Part-2: Paliperidone Palmitate (PP) | -0.2 | Standard Error 1.08 | T-score | |
| Part 2 (Disease Progression): Change From Baseline in Working Memory Score: MCCB Domain | Part-2: OAP | -0.8 | Standard Error 0.77 | T-score | |
| Part 2 (Disease Progression): Change From Baseline in Verbal Learning Score: MCCB Domain | Part-2: Paliperidone Palmitate (PP) | 1.3 | Standard Error 1.22 | T-score | |
| Part 2 (Disease Progression): Change From Baseline in Verbal Learning Score: MCCB Domain | Part-2: OAP | 1.0 | Standard Error 0.85 | T-score | |
| Part 2 (Disease Progression): Change From Baseline in Speed of Processing Score: MCCB Domain | Part-2: Paliperidone Palmitate (PP) | 1.8 | Standard Error 1.21 | T-score | |
| Part 2 (Disease Progression): Change From Baseline in Speed of Processing Score: MCCB Domain | Part-2: OAP | 3.5 | Standard Error 0.87 | T-score | |
| Part 2 (Disease Progression): Change From Baseline in Attention/Vigilance Score: MCCB Domain | Part-2: Paliperidone Palmitate (PP) | 3.2 | Standard Error 1.18 | T-score |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02431702/results